Related references
Note: Only part of the references are listed.Widespread and Functional RNA Circularization in Localized Prostate Cancer
Sujun Chen et al.
CELL (2019)
Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
H. Ballentine Carter et al.
EUROPEAN UROLOGY (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned
Lisa M. Lowenstein et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Walter Artibani et al.
UROLOGIA INTERNATIONALIS (2018)
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
Christos Mikropoulos et al.
BRITISH JOURNAL OF CANCER (2018)
The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
Shadrielle Melijah G. Espiritu et al.
CELL (2018)
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through IncRNA PCAT19
Junjie Tony Hua et al.
CELL (2018)
Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria
Melanie A. Evans et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
David C. Wedge et al.
NATURE GENETICS (2018)
Historical and contemporary perspectives on cribriform morphology in prostate cancer
Matthew Truong et al.
NATURE REVIEWS UROLOGY (2018)
Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
Gail P. Risbridger et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
Clarissa Gerhauser et al.
CANCER CELL (2018)
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells
Laura H. Porter et al.
BJU INTERNATIONAL (2018)
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories
Laura H. Porter et al.
EUROPEAN UROLOGY (2017)
A Prostate Cancer Nimbosus'': Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L. K. Chua et al.
EUROPEAN UROLOGY (2017)
The Evolving Narrative of DNA Repair Gene Defects: Distinguishing Indolent from Lethal Prostate Cancer
Declan G. Murphy et al.
EUROPEAN UROLOGY (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
Crucial role of noncoding RNA in driving prostate cancer development and progression
Haiyang Guo et al.
EPIGENOMICS (2017)
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
Renea A. Taylor et al.
NATURE COMMUNICATIONS (2017)
Mitochondrial mutations drive prostate cancer aggression
Julia F. Hopkins et al.
NATURE COMMUNICATIONS (2017)
Androgen receptor and miR-206 regulation in prostate cancer
Fu Y. Chua et al.
TRANSCRIPTION-AUSTIN (2017)
Prostate Cancer Screening in a New Era of Genetics
Heather H. Cheng et al.
CLINICAL GENITOURINARY CANCER (2017)
Relevance of DNA damage repair in the management of prostate cancer
Patricia Banks et al.
CURRENT PROBLEMS IN CANCER (2017)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2016)
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation
Masashi Kato et al.
MODERN PATHOLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
Yunee Kim et al.
NATURE COMMUNICATIONS (2016)
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers
E. Castro et al.
ANNALS OF ONCOLOGY (2015)
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S. Gillessen et al.
ANNALS OF ONCOLOGY (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
Gail P. Risbridger et al.
EUROPEAN UROLOGY (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
Colin S. Cooper et al.
NATURE GENETICS (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Establishment of Primary Patient-Derived Xenografts of Palliative TURP Specimens to Study Castrate-Resistant Prostate Cancer
Mitchell G. Lawrence et al.
PROSTATE (2015)
The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
Zhibin Chen et al.
PROSTATE (2015)
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth K. Bancroft et al.
EUROPEAN UROLOGY (2014)
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Emilie Lalonde et al.
LANCET ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Copy number alteration burden predicts prostate cancer relapse
Haley Hieronymus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens
Kyosuke Kimura et al.
PROSTATE (2014)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
Meelan Bul et al.
EUROPEAN UROLOGY (2013)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
4FISH-IF, a Four-Color Dual-Gene FISH Combined with p63 Immunofluorescence to Evaluate NKX3.1 and MYC Status in Prostate Cancer
Dominique Trudel et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
A preclinical xenograft model of prostate cancer using human tumors
Mitchell G. Lawrence et al.
NATURE PROTOCOLS (2013)
Risk stratification in prostate cancer screening
Monique J. Roobol et al.
NATURE REVIEWS UROLOGY (2013)
A Preclinical Xenograft Model Identifies Castration-Tolerant Cancer-Repopulating Cells in Localized Prostate Tumors
Roxanne Toivanen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
Gaetano Zafarana et al.
CANCER (2012)
NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy
Jennifer A. Locke et al.
CLINICAL CANCER RESEARCH (2012)
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
T. Van der Kwast et al.
EUROPEAN JOURNAL OF CANCER (2012)
Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer
Yunee Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Histologic Changes Associated With Neoadjuvant Chemotherapy Are Predictive of Nodal Metastases in Patients With High-Risk Prostate Cancer
Catherine O'Brien et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Morphologic Characterization of Preoperatively Treated Prostate Cancer: Toward a Post-Therapy Histologic Classification
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2010)
Brca2 and Trp53 Deficiency Cooperate in the Progression of Mouse Prostate Tumourigenesis
Jeffrey C. Francis et al.
PLOS GENETICS (2010)
High-Resolution Array CGH Identifies Novel Regions of Genomic Alteration in Intermediate-Risk Prostate Cancer
Adrian S. Ishkanian et al.
PROSTATE (2009)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
Charles C. Guo et al.
MODERN PATHOLOGY (2006)
Share Paper
